Skip to main content
. 2018 Jul 20;9(56):30731–30747. doi: 10.18632/oncotarget.24578

Table 3. The p-values, fold changes, sensitivity, specificity, and AUC values of HSPE1 ROC curves.

Expression level of HSPE1 Different comparison Fold change (BC/control) p-value for diagnosis AUC (sensitivity/specificity) Optimal cutoff point (score for tissue; ng/ml for urine)
Tissue Bladder cancer (n = 92) vs Adjacent normal (n = 19) 4.68 <0.0001 0.92 (92.39%/78.95%) 110
Urine Bladder cancer (n = 126) vs Hernia (n = 142) 2.51 <0.01 0.60 (75.40%/42.25%) 0.074
Low-grade BC (n = 42) vs Hernia (n = 142) 2.48 <0.05 0.60 (59.52%/68.31%) 0.204
Early-stage BC (n = 98) vs Hernia (n = 142) 2.46 <0.01 0.61 (52.04%/68.31%) 0.204
Bladder cancer (n = 126) vs Hematuria (n = 67) 3.48 <0.01 0.63 (57.94%/65.67%) 0.155
Bladder cancer (n = 126) vs Urinary tract infection (n = 59) 3.87 <0.01 0.63 (38.10%/84.75%) 0.261